FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Martin Avenue Pharmacy Vancomycin 25 mg/mL opthalmic solution Recall

Vancomycin 25 mg/mL opthalmic solution packaged in an opaque squeeze bottle eye dropper…

Martin Avenue Pharmacy, Inc. · Naperville, IL

Risk level
Class II
Reported by FDA
Nov 5, 2014
Recall ID
D-0168-2015
Check your lot numberHow we source this data

Summary

Martin Avenue Pharmacy recalled Vancomycin 25 mg/mL opthalmic solution starting Aug 27, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0168-2015 on Nov 5, 2014. Reason: Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Product description

Vancomycin 25 mg/mL opthalmic solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.

Lot numbers, UPCs & expiration codes

Lot Number: 06102014@40, Exp 9/8/2014

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0168-2015
Classification
Class II
Status
Terminated
Recall initiated
Aug 27, 2014
FDA report date
Nov 5, 2014
Quantity
20 mL
Recall type
Voluntary: Firm initiated
Recalling firm
Martin Avenue Pharmacy, Inc.

Original FDA data

Every field from FDA enforcement report D-0168-2015, exactly as published.

Show all FDA fields
City
Naperville
State
IL
Status
Terminated
Country
United States
Event ID
69152
Address
1247 Rickert Dr
Code information
Lot Number: 06102014@40, Exp 9/8/2014
Postal code
60540-1008
Report date
Nov 5, 2014
Product type
Drugs
Recall number
D-0168-2015
Classification
Class II
Recalling firm
Martin Avenue Pharmacy, Inc.
Product quantity
20 mL
Termination date
May 31, 2018
Reason for recall
Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Vancomycin 25 mg/mL opthalmic solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
Distribution pattern
Nationwide
Recall initiation date
Aug 27, 2014
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Oct 29, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0168-2015, published Nov 5, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls